Novel design principle validated: Glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent

Fájlok

Bioorganic and Medicinal Chemistry Letters. -18 (2008), p. 5680-5683. -Bioorg. Med. Chem. - 0968-0896

open access pre-print és post- print (24h embargó)
Elsevier
http://creativecommons.org/licenses/by-nc-nd/4.0/